Primary immune thrombocytopenia
Conditions
Sponsors
Jiaozuo People's Hospital
Eligibility
Sex/Gender
All
Age
14 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Subjects who meet the diagnostic criteria of "Chinese expert consensus on diagnosis and treatment of adult primary immune thrombocytopenia" (2016 Edition); 2. Subjects aged 14 years and <= 70 years; 3. Subjects without severe organ dysfunction; 4. Those who have no allergic history to this group of drugs; 5. Each subject (or his / her legal representative) must sign an informed consent form indicating that he / she understands the purpose and procedure of the study and is willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with malignant diseases other than ITP who need to receive treatment recently or in the near future; 2. Patients with severe liver and kidney function and cardiopulmonary dysfunction, patients with coronary heart disease, hypertension and mental illness; 3. Patients who had undergone cardiac bypass surgery and transplantation, and patients within 1 month after various operations; 4. Patients with severe bleeding or menstrual period, pregnancy and lactation period; 5. Patients with uncontrolled or severe infection; 6. Patients with intractable or severe constipation; 7. Patients who can not cooperate with the therapy; 8. Patients or family members request to withdraw from the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding Score;Platelet count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reaction; | — |
Countries
China
Contacts
Public ContactQinglin Song
Jiaozuo People's Hospital
Outcome results
None listed